Catalysts for Glenmark Pharmaceuticals Ltd
65 tracked
Apr 25, 2026
phase 2 initiation
Glenmark Pharmaceuticals Ltd — (clascoterone + latanoprost) (Phase II Trial Initiation)
(clascoterone + latanoprost)
→
Apr 17, 2026
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 17, 2026
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 10, 2026
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 8, 2026
approval
PROGESTERONE — FDA approval
PROGESTERONE
→
Mar 16, 2026
approval
FLUTICASONE PROPIONATE — FDA approval
Fluticasone Propionate Glenmark
→
Jan 21, 2026
approval
LACOSAMIDE — FDA approval
Glenmark Pharmaceuticals Ltd
→
Jan 18, 2026
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Jan 16, 2026
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Jan 5, 2026
approval
SUCRALFATE — FDA approval
SUCRALFATE
→
Dec 4, 2025
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Oct 17, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Oct 17, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Oct 17, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Oct 17, 2025
approval
TACROLIMUS — FDA approval
tacrolimus ER
→
Oct 1, 2025
approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
→
Oct 1, 2025
approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
→
Oct 1, 2025
approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approval
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
→
Aug 6, 2025
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Jan 22, 2025
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Jan 22, 2025
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Jul 16, 2024
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Apr 11, 2024
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 11, 2024
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Feb 22, 2024
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Feb 16, 2023
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Feb 16, 2023
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Feb 16, 2023
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Feb 16, 2023
approval
TOPIRAMATE — FDA approval
topiramate ER
→
Feb 16, 2023
approval
TOPIRAMATE — FDA approval
topiramate ER
→